Circulating hormones and risk of gastric cancer by subsite in three cohort studies.

"Declarations Conflict of interestNone of the authors have any conflicts of interest to disclose. Ethics statementAll participants provided written informed consent. Ethical approval of the EPIC cohort study was obtained from the ethical review committees of the IARC and EPIC centers. The ATBC study was approved by the Institutional Review Boards of both the NIH in the United States and the National Public Health Institutes in Finland. The UK Biobank cohort study was approved by Northwest Multi-center Research Ethics Committee, the National Information Governance Board for Health and Social Care in England and Wales, and the Community Health Index Advisory Group in Scotland. DisclaimerWhere authors are identified as personnel of the IARC/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the IARC/World Health Organization. Conflict of interest None of the authors have any conflicts of interest to disclose."

"Funding Research was funded by the Stand Up to Cancer campaign for Cancer Research UK; award number: C53889/A20189."